CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts

Experimental Hematology

Volumn 30, Issue 11, 2002, Pages 1283-1292

  Aldinucci, Donatella ^a   Poletto, Dalisa ^a   Nanni, Paola ^a   Degan, Massimo ^a   Rupolo, Maurizio ^a   Pinto, Antonio ^a   Gattei, Valter ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD15 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 3; INTERLEUKIN 4; LIPOCORTIN 5; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; PROTEIN BCL XL; TUMOR NECROSIS FACTOR ALPHA;

ACCESSORY CELL; ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CELL ADHESION; CELL AGGREGATION; CELL GROWTH; CELL PROLIFERATION; CELL RENEWAL; CLONOGENESIS; COLONY FORMING CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EFFECTOR CELL; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD40; APOPTOSIS; BCL-X PROTEIN; CD40 LIGAND; CELL ADHESION; CELL DIVISION; CYTOKINES; GENE EXPRESSION REGULATION, LEUKEMIC; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; INTERLEUKINS; LEUKEMIA, MYELOID; MICE; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SOLUBILITY; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TUMOR STEM CELL ASSAY; TUMOR STEM CELLS;

EID: 0036841640     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00921-9     Document Type: Article

References (64)

1. Bradstock K.F., Gottlieb D.J. Interaction of acute leukemia cells with the bone marrow microenvironment. implications for control of minimal residual disease Leuk Lymphoma. 18:1995;1.
2. Garrido S.M., Appelbaum F.R., Willman C.L., Banker D.E. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). Exp Hematol. 29:2001;448.
3. Cross M., Dexter T.M. Growth factors in development, transformation, and tumorigenesis. Cell. 64:1991;271.
4. Rogers S.Y., Bradbury D., Kozlowski R., Russell N.H. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells. Exp Hematol. 22:1994;593.
5. + cells. Leukemia. 6:1992;562.
6. Nigam A.K. Adhesion molecules in cancer. Eur J Surg Oncol. 20:1994;82.
7. Ruoslahti E., Reed J.C. Anchorage dependence, integrins, and apoptosis. Cell. 77:1994;477.
8. Reilly I.A., Kozlowski R., Russell N.H. Heterogeneous mechanisms of autocrine growth of AML blasts. Br J Haematol. 72:1989;363.
9. Massague J., Pandiella A. Membrane-anchored growth factors. Annu Rev Biochem. 62:1993;515.
10. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF Receptor superfamilies. integrating mammallian biology Cell. 104:2001;487.
11. Gattei V., Degan M., Gloghini A.et al. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. Blood. 89:1997;2048.
12. Rossi F.M., Degan M., Mazzocut-Zecchin L.et al. CD30L upregulates CD30 and IL-4 expression by T cells. FEBS Lett. 508:2001;418.
13. + normal T cells. Br J Haematol. 117:2002;59.
14. Min Y.H., Lee S., Lee J.W., Chong S.Y., Hahn J.S., Ko Y.W. Expression of Fas antigen in acute myeloid leukaemia is associated with therapeutic response to chemotherapy. Br J Haematol. 93:1996;928.
15. Lewis N.R., Pallis M., Russell N.H. Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia. Exp Hematol. 28:2000;535.
16. Costello R.T., Mallet F., Sainty D., Maraninchi D., Gastaut J.A., Olive D. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition. Eur J Immunol. 28:1998;90.
17. - leukemic progenitors Leukemia. 13:1998;1513.
18. Costello R.T., Mallet F., Chambost H.et al. Acute myeloid leukemia triggering via CD40 induces leukocyte chemoattraction and cytotoxicity against allogenic or autologous leukemic targets. Leukemia. 14:2000;123.
19. Brouwer R.E., van der Hoorn M., Kluin-Nelemans H.C., van Zelderen-Bhola S., Willemze R., Falkenburg J.H. The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses. Hum Immunol. 61:2000;565.
20. Costello R.T., Gastaut J.A., Olive D. What is the real role of CD40 in cancer immunotherapy? Immunol Today. 20:1999;488.
21. Brouwer R.E., Hoefnagel J., van Der Burg B.B.et al. Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia. high CD40 and CD11a expression correlates with poor prognosis Br J Haematol. 115:2001;298.
22. Garrone P., Neidhardt E.M., Garcia E., Galibert L., van Kooten C., Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med. 182:1995;1265.
23. Bennett J.M., Catovsky D., Daniel M.T.et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 103:1985;620.
24. Carbone A., Gloghini A., Gattei V.et al. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood. 85:1995;780.
25. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156.
26. Degan M., Mazzocco F.T., Di Francia R., Rossi F.M., Pinto A., Gattei V. Normalizing complementary DNA by quantitative reverse transcriptase-polymerase chain reaction of β2-microglobulin. molecular monitoring of minimal residual disease in acute promyelocytic leukemia Diagn Mol Pathol. 9:2000;98.
27. Aldinucci D., Poletto D., Gloghini A.et al. Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells. Am J Pathol. 160:2002;585.
28. Alderson M.R., Armitage R.J., Tough T.W., Strockbin L., Fanslow W.C., Spriggs M.K. CD40 expression by human monocytes. regulation by cytokines and activation of monocytes by the ligand for CD40 J Exp Med. 178:1993;669.
29. Stamenkovic I., Clark E.A., Seed B. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8:1989;1403.
30. Galy A.H., Spits H. CD40 is functionally expressed on human thymic epithelial cells. J Immunol. 149:1992;775.
31. Quentmeier H., Zaborski M., Drexler H.G. The human bladder carcinoma cell line 5637 constitutively secretes functional cytokines. Leuk Res. 21:1997;343.
32. Pinto A., Aldinucci D., Gattei V.et al. Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3′,5′-cyclic monophosphate. Proc Natl Acad Sci U S A. 89:1992;8884.
33. Peguet-Navarro J., Dalbiez-Gauthier C., Moulon C.et al. CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. J Immunol. 158:1997;144.
34. Challa A., Holder M., Baker M., Pound J., Gordon J. CD40 Workshop Panel report. Kishimoto T., Kikutani H., E G K von dem Borne A.et al. Leucocyte Typing VI. White Cell Differentiation Antigens:1997;Garland Publishing, New York. 159p.
35. Karmann K., Hughes C.C., Schechner J., Fanslow W.C., Pober J.S. CD40 on human endothelial cells. inducibility by cytokines and functional regulation of adhesion molecule expression Proc Natl Acad Sci U S A. 92:1995;4342.
36. + hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J Exp Med. 185:1997;341.
37. Andersen N.S., Larsen J.K., Christiansen J.et al. Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures. Blood. 96:2000;2219.
38. Nara N., Kurokawa H., Tanikawa S., Tomiyama J., Nagata K. Prognostic significance of the blast self-renewal capacity in patients with acute myeloid leukemia. Cancer. 73:1994;92.
39. Suttles J., Evans M., Miller R.W., Poe J.C., Stout R.D., Wahl L.M. T cell rescue of monocytes from apoptosis. role of the CD40-CD40L interaction and requirement for CD40-mediated induction of protein tyrosine kinase activity J Leukoc Biol. 60:1996;651.
40. Wang Z., Karras J.G., Howard R.G., Rothstein T.L. Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells. J Immunol. 155:1995;3722.
41. Reilly I.A., Kozlowski R., Russell N.H. The role of cell contact and autostimulatory soluble factors in the proliferation of blast cells in acute myeloblastic leukemia. Leukemia. 3:1989;145.
42. Klickstein L.B., Springer T.A. CD54 (ICAM-1) cluster report. Schlossmann S., Boumsell L., Gilks W.et al. Proceedings of the 5th International Workshop on Human Leukocyte Antigens. 1995;Oxford University Press, Oxford, UK. 1882p.
43. Urashima M., Chauhan D., Uchiyama H., Freeman G.J., Anderson K.C. CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood. 85:1995;1903.
44. Kipps T.J., Chu P., Wierda W.G. Immunogenetic therapy for B-cell malignancies. Semin Oncol. 27:2000;104.
45. th Annual Meeting of the American Society of Hematology, Orlando (FL), December 7-11. Blood 98(Suppl 1):2467(589a)
46. + leukaemia Br J Haematol. 102:1998;1257.
47. Gattei V., Degan M., Rossi F.M.et al. CD30 ligand (CD30L)-expressing acute myeloid leukemias. a new model of paracrine interactions for the regulation of blast cell proliferation Leuk Lymphoma. 35:1999;21.
48. Biancone L., Cantaluppi V., Boccellino M.et al. Activation of CD40 favors the growth and vascularization of Kaposi's sarcoma. J Immunol. 163:1999;6201.
49. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature. 414:2001;105.
50. Begley C.G., Metcalf D., Nicola N.A. Binding characteristics and proliferative action of purified granulocyte colony-stimulating factor (G-CSF) on normal and leukemic human promyelocytes. Exp Hematol. 16:1988;71.
51. Moore M.A., Williams N., Metcalf D. In vitro colony formation by normal and leukemic human hematopoietic cells. characterization of the colony-forming cells J Natl Cancer Inst. 50:1973;603.
52. Reed J.C. bcl-2 family proteins. Oncogene. 17:1998;3225.
53. Boise L.H., Thompson C.B. bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc Natl Acad Sci U S A. 94:1997;3759.
54. Zhu Y.M., Bradbury D.A., Keith F.J., Russell N. Absence of retinoblastoma protein expression results in autocrine production of interleukin-6 and promotes the autonomous growth of acute myeloid leukemia blast cells. Leukemia. 8:1994;1982.
55. Onetto-Pothier N., Aumont N., Haman A.et al. Characterization of granulocyte-macrophage colony-stimulating factor receptor on the blast cells of acute myeloblastic leukemia. Blood. 75:1990;59.
56. Biancone L., Cantaluppi V., Camussi G. CD40-CD154 interaction in experimental and human disease. Int J Mol Med. 3:1999;343.
57. Mach F., Schonbeck U., Sukhova G.K.et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages. implications for CD40-CD40 ligand signaling in atherosclerosis Proc Natl Acad Sci U S A. 94:1997;1931.
58. Solanilla A., Dechanet J., El Andaloussi A.et al. CD40-ligand stimulates myelopoiesis by regulating flt3-ligand and thrombopoietin production in bone marrow stromal cells. Blood. 95:2000;3758.
59. Pietravalle F., Lecoanet-Henchoz S., Blasey H.et al. Human native soluble CD40L is a biologically active trimer, processed inside microsomes. J Biol Chem. 271:1996;5965.
60. Clodi K., Asgari Z., Younes M.et al. Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease. potential therapeutic significance Cancer. 94:2002;1.
61. Viallard J.F., Solanilla A., Gauthier B.et al. Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood. 99:2002;2612.
62. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:1998;275.
63. MacDonald A.S., Straw A.D., Dalton N.M., Pearce E.J. Cutting edge. Th2 response induction by dendritic cells: a role for CD40 J Immunol. 168:2002;537.
64. + acute myeloid leukemia in first relapse. J Clin Oncol. 19:2001;3244.